Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Immunoblastic Lymphadenopathy × Imatinib Mesylate × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 36 Leukemia 26 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Gastrointestinal Stromal Tumors 13 Leukemia, Myeloid, Chronic-Phase 12 Leukemia, Myeloid 6 Brain Neoplasms 6 Prostatic Neoplasms 5 Philadelphia Chromosome 5 Blast Crisis 5 Sarcoma 4 Recurrence 4 Glioblastoma 4 Carcinoma, Non-Small-Cell Lung 4 Bone Marrow Diseases 4 Ovarian Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematologic Diseases 3 Bronchiolitis Obliterans Syndrome 3 Breast Neoplasms 3 Stomach Neoplasms 2 Polycythemia Vera 2 Neurofibromatoses 2 Neoplasms by Histologic Type 2 Neoplasms 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Meningioma 2

Interventions

fludarabine phosphate 15 Cyclophosphamide 13 Whole-Body Irradiation 12 Peripheral Blood Stem Cell Transplantation 12 Tacrolimus 10 Etoposide 10 Rituximab 8 Mycophenolic Acid 8 Methotrexate 6 Melphalan 6 Cyclosporine 6 Busulfan 6 Antilymphocyte Serum 6 Vorinostat 4 Sirolimus 4 Prednisone 4 Lenalidomide 4 Immunohistochemistry 4 Gene Expression Profiling 4 Carboplatin 4 Vincristine 3 Microarray Analysis 3 Gemcitabine 3 Everolimus 3 Doxorubicin 3 Dexamethasone 3 Brentuximab Vedotin 3 Alemtuzumab 3 10-propargyl-10-deazaaminopterin 3 thymoglobulin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡